Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is interesting

Well..... I will pledge my shares to a buy-out... The company has .05-.06 cents a share in cash(as of last 1/4)... We actually have between .06 to .28.... with recent settlements.... It would not take much to buy them out....

 

 

OPPS though the TPL PTSC deal would be turned... TPL would retian patent rights unless they agree....

Share
New Message
Please login to post a reply